Gene · 5499
Papers4,146
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,146
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Promising role of Vitamin D and plant metabolites against COVID-19: Clinical trials review. | Heliyon | 2023 | 37920525 | PubTator, text mining | PubMed |
| COVID-19 and Gastrointestinal Tract: From Pathophysiology to Clinical Manifestations. | Medicina (Kaunas) | 2023 | 37893427 | PubTator, text mining | PubMed |
| The Sphingolipid-Signaling Pathway as a Modulator of Infection by SARS-CoV-2. | Curr Issues Mol Biol | 2023 | 37886946 | PubTator, text mining | PubMed |
| Identification of the role of endoplasmic reticulum stress genes in endometrial cancer and their association with tumor immunity. | BMC Med Genomics | 2023 | 37880674 | PubTator, text mining | PubMed |
| What are the current anti-COVID-19 drugs? From traditional to smart molecular mechanisms. | Virol J | 2023 | 37875904 | PubTator, text mining | PubMed |
| Distinct mechanisms drive sequential internalization and degradation of GABAARs during global ischemia and reperfusion injury. | iScience | 2023 | 37860758 | PubTator, text mining | PubMed |
| Mass spectrometric assays monitoring the deubiquitinase activity of the SARS-CoV-2 papain-like protease inform on the basis of substrate selectivity and have utility for substrate identification. | Bioorg Med Chem | 2023 | 37857256 | PubTator, text mining | PubMed |
| Synthesis and Biological Evaluation of Benzothiazolyl-pyridine Hybrids as New Antiviral Agents against H5N1 Bird Flu and SARS-COV-2 Viruses. | ACS Omega | 2023 | 37841136 | PubTator, text mining | PubMed |
| Persistence is key: unresolved immune dysfunction is lethal in both COVID-19 and non-COVID-19 sepsis. | Front Immunol | 2023 | 37822940 | PubTator, text mining | PubMed |
| The N-terminal peptide of the main protease of SARS-CoV-2, targeting dimer interface, inhibits its proteolytic activity. | BMB Rep | 2023 | 37817441 | PubTator, text mining | PubMed |
| Antcin-B, a phytosterol-like compound from Taiwanofungus camphoratus inhibits SARS-CoV-2 3-chymotrypsin-like protease (3CLPro) activity in silico and in vitro. | Sci Rep | 2023 | 37816832 | PubTator, text mining | PubMed |
| Antiviral and antimicrobial applications of chalcones and their derivatives: From nature to greener synthesis. | Heliyon | 2023 | 37810815 | PubTator, text mining | PubMed |
| PIM1 controls GBP1 activity to limit self-damage and to guard against pathogen infection. | Science | 2023 | 37797010 | PubTator, text mining | PubMed |
| A new perspective on Alzheimer's disease: microRNAs and circular RNAs. | Front Genet | 2023 | 37790702 | PubTator, text mining | PubMed |
| Phosphoprotein phosphatase activity positively regulates oligomeric pyrin to trigger inflammasome assembly in phagocytes. | mBio | 2023 | 37787552 | PubTator, text mining | PubMed |
| Tumor Suppressor LncRNA on Chromosome 8p12 (TSLNC8): A Concise Review in Human Malignancies. | J Cancer | 2023 | 37781073 | PubTator, text mining | PubMed |
| Epidemiological investigation and pathogenicity of porcine reproductive and respiratory syndrome virus in Sichuan, China. | Front Microbiol | 2023 | 37779701 | PubTator, text mining | PubMed |
| Lichen or Associated Micro-Organism Compounds Are Active against Human Coronaviruses. | Viruses | 2023 | 37766264 | PubTator, text mining | PubMed |
| Feline Infectious Peritonitis: European Advisory Board on Cat Diseases Guidelines. | Viruses | 2023 | 37766254 | PubTator, text mining | PubMed |
| One-Step Assembly of a PRRSV Infectious cDNA Clone and a Convenient CRISPR/Cas9-Based Gene-Editing Technology for Manipulation of PRRSV Genome. | Viruses | 2023 | 37766223 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5499/papers?page=8